Drug intelligence / Profile preview

PreLipid

Development stage
Unknown
Lead developer
PreEmptive Meds
Administration
Oral
01

Overview

PreLipid is a fixed-dose combination nutritional supplement (nutraceutical) developed by Abbott Healthcare for the management of hyperlipidemia and borderline dyslipidemia. The formulation consists of red yeast rice (Monascus purpureus), grape seed extract (Vitis vinifera), and black pepper extract (Piper nigrum). The primary active component in red yeast rice is monacolin K, which acts as a natural HMG-CoA reductase inhibitor to reduce endogenous cholesterol synthesis. Grape seed extract provides antioxidant support through its high concentration of proanthocyanidins, while black pepper extract (containing piperine) is included to enhance the bioavailability of the other ingredients. Clinical studies, including post-marketing assessments in India, have demonstrated its efficacy in improving lipid profiles by reducing total cholesterol, LDL-C, and triglycerides, and its safety for primordial prevention in patients with mildly elevated lipid levels.

Brand names
PreLipid
Other names
NS-YGP
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on PreLipid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PreLipid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call